Agile Therapeutics, Inc. Aktie News
0,40 $
0,00 %
gestern
Nasdaq,
26. April, 20:59 Uhr
tracken
Agile Therapeutics, Inc. Aktie News
Neutral
Seeking Alpha
●
30 Tage alt
Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript
Neutral
GlobeNewsWire
●
30 Tage alt
Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2024 from Decreased Demand in Fourth Quarter 2023 Management to Host Conference Call Today, Thursday, March 28, 2024 at 8:30 a....
Neutral
GlobeNewsWire
●
etwa ein Monat alt
PRINCETON, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile Therapeutics” or the “Company”), a women's healthcare company, today announced that the Company has received a final delisting notice from Nasdaq.
Neutral
GlobeNewsWire
●
etwa ein Monat alt
PRINCETON, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023 financial results before the market opens on Thursday, March 28, 2024.
Neutral
GlobeNewsWire
●
etwa ein Monat alt
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023 financial results before the market opens on Friday, March 22, 2024.
Neutral
GlobeNewsWire
●
etwa ein Monat alt
Elimination of Remaining Debt to Perceptive Advisors Leaves the Company's Balance Sheet Debt Free Elimination of Remaining Debt to Perceptive Advisors Leaves the Company's Balance Sheet Debt Free
Neutral
GlobeNewsWire
●
2 Monate alt
PRINCETON, N.J., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile Therapeutics” or the “Company”), a women's healthcare company, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 3,892,572 shares of common stock of the Company originally issued in July 2022 and May 2...
Positiv
InvestorPlace
●
2 Monate alt
Agile Therapeutics (NASDAQ: AGRX ) stock is rocketing higher on Thursday alongside heavy trading of the women's healthcare company's shares. During pre-market trading this morning, more than 7.5 million shares of AGRX stock have been traded.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
